AMENDED AND RESTATED 2011 SECURITIES PURCHASE AGREEMENT2011 Securities Purchase Agreement • March 17th, 2015 • Champions Oncology, Inc. • Biological products, (no disgnostic substances) • New York
This AMENDED AND RESTATED 2011 SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of March 13, 2015, by and between Champions Oncology, Inc. (the “Company”) (previously known as Champions Biotechnology, Inc.), Battery Ventures IX, L.P. (“Ventures”), Battery Investment Partners IX, LLC (together with Ventures, “Battery”), Joel Ackerman (“Ackerman”) and Ronnie Morris (“Morris”) amends and restates in its entirety the Securities Purchase Agreement dated as of March 24, 2011 (the “Original 2011 Securities Purchase Agreement”) between the Company, Battery, Ackerman, Morris and the other parties to the Original 2011 Securities Purchase Agreement (such parties, Battery, Ackerman and Morris being the “Investors”), as amended by the Amendment No. 1 to 2011 Securities Purchase Agreement dated January 29, 2014.
AMENDMENT NO. 1 TO2011 Securities Purchase Agreement • February 6th, 2014 • Champions Oncology, Inc. • Biological products, (no disgnostic substances)
This Amendment No. 1 (this “Amendment”), dated as of January 29, 2014, is by and among Champions Oncology, Inc. (the “Company”), Battery Ventures IX, L.P. (“Ventures”) and Battery Investment Partners IX, LLC (together with Ventures, “Battery”).
